Decaris

Decaris is an anthelmintic from the group of benzimidazole derivatives.

Indications for use

Decaris is prescribed for ascariasis - a helminthic infestation caused by roundworms. The drug is effective for both intestinal and extraintestinal ascariasis.

Directions for use and doses

Decaris is taken orally once, usually in the evening.

Adults are prescribed 1 tablet (150 mg).

Children aged 1 to 6 years - 1⁄2-1 tablets (50 mg).

Children from 7 to 14 years old - 1-2 tablets (150-300 mg).

Side effects

Possible abdominal pain, nausea, vomiting, diarrhea.

Release form

Tablets of 0.15 g (150 mg) and 0.05 g (50 mg).

Decaris: a drug to stimulate the immune system

Decaris (international name - levamisole) is a drug that is used to stimulate immune processes. It is produced by Gedeon Richter in Hungary.

Decaris is available in two dosage forms: 50 mg tablets and 150 mg tablets. Its active substance is levamisole.

Indications for use of Decaris include the treatment of Duke colon cancer (adjuvant therapy after colon resection) and immunodeficiency conditions, including autoimmune diseases such as rheumatoid arthritis, Crohn's disease, recurrent aphthous stomatitis, Reiter's disease and systemic lupus erythematosus. It is also used to treat chronic nonspecific lung diseases, chronic glomerulonephritis, chronic pyelonephritis, gastric and duodenal ulcers, toxoplasmosis, ascariasis, necatoriasis and strongyloidiasis.

Despite the fact that Decaris is an effective medicine, it has some contraindications. It should not be used in patients with hypersensitivity to levamisole, agranulocytosis, children under 14 years of age, pregnant or lactating women.

When using Dekaris, side effects may occur, such as dyspeptic symptoms, pancreatitis, impaired consciousness, olfactory hallucinations, agranulocytosis, increased concentrations of creatinine and alkaline phosphatase in the blood serum, generalized convulsions, encephalitis-like syndrome, paresthesia, peripheral polyneuropathy, speech disorders, lethargy, muscle weakness, periorbital edema, kidney damage, uterine bleeding, exfoliative dermatitis and allergic reactions.

Decaris may also interact with other medications. It enhances the effects of phenytoin and indirect anticoagulants, and is incompatible with alcohol.

Before starting treatment with Dekaris, it is necessary to conduct a peripheral blood test. There is no data on how Decaris interacts with other drugs in overdose.

In conclusion, Decaris is an effective immune stimulating drug that can be used to treat various immunodeficiency conditions and other diseases. However, it has some contraindications and side effects, so its use should only be prescribed by a doctor who will assess the benefits and risks for each individual patient. Before starting treatment with Decaris, you must consult your doctor and follow his recommendations.